News CapFlex finger joint prosthesis now in use in Australia
Developed at Schulthess Klinik, the CapFlex prosthesis is now also approved for use in Australia and is available to hand surgeons across the country. The prosthesis can be used to treat conditions such as severe osteoarthritis of the interphalangeal joint.
The CapFlex prosthesis was developed by Dr Daniel Herren and Dr Stephan Schindele, and is sold by the KLS Martin Group. In light of the good results achieved during the treatment of patients at Schulthess Klinik, the device has now been approved for use in Australia.
The approval is based on the two-year results and the resulting trial carried out by our research team. The team’s work on the trial was also recently recognised by the renowned Journal of Hand Surgery European Volume, winning the JHSE Editors’ Award.
The image shows the official market launch with James Taylor (Product Manager at the KLS Martin Group Australia, top left), Chris Williams (hand surgeon from England, top right) and Stephan Schindele (Co-Head of Hand Surgery at Schulthess Klinik, bottom left). The CapFlex prosthesis is pictured bottom right.
